Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 28 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMACIE DE BOUSVAL from Genappe, company number BE0479811884, closed financial year 2025 with a result of € -16,998 after tax. For that financial year PHARMACIE DE BOUSVAL recorded a gross margin of € 3,780 and equity of € 59,775. Compared with financial year 2024, the result moved from € -18,254 to € -16,998. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.
€ 59,775
▼ 22% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -16,998
▲ 7 % less loss than in 2024
Profit after tax over the fiscal year.
€ 804
▼ 85% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -2,225.
People and assets in 2025
€ 2,029
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1,830
▼ 10% vs 2024
Loans from banks and other lenders, long and short.
€ 19,272
▼ 9% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 238
▼ 13% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 39,755 | € 9,804 | € 4,821 | € 3,780 | ▼ 22% |
| Profit after taxes | € 1,357 | € -17,536 | € -18,254 | € -16,998 | ▲ € 1,256 |
| Equity | € 112,563 | € 95,027 | € 76,773 | € 59,775 | ▼ 22% |
| Total debts | € 135,261 | € 112,654 | € 93,548 | € 79,841 | ▼ 15% |
| Cash | € 65,036 | € 29,874 | € 5,235 | € 804 | ▼ 85% |
| Land & buildings | € 1,611 | - | - | - | |
| Retained profit | € 50,563 | € 33,027 | € 14,773 | € -2,225 | ▼ € 16,998 |
| Bank debt | € 35,180 | € 32,022 | € 2,025 | € 1,830 | ▼ 10% |
| Balance sheet total | € 247,824 | € 207,682 | € 170,321 | € 139,616 | ▼ 18% |
Key figures of PHARMACIE DE BOUSVAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE DE BOUSVAL?
What happened at PHARMACIE DE BOUSVAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 16,998. Source: NBB ↗
- PIERRE LEVAQUE stepped down as director. NBB
- PIERRE LEVAQUE became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 1,357 profit in 2022 to € 16,998 loss in 2025.
Paid € 8,736 in corporate taxes since 2022.
Best year ever: 2022, with € 1,357 profit.
Management
Directors
According to the 2025 annual accounts
PIERRE LEVAQUE
Managing director
since 2020 · until 2026
Establishments
Establishment units
Physical locations of this company
Place Communale 1
1470 Genappe
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0479.811.884
- VAT number
- BE 0479.811.884
- Registered office
- Place Communale 1, 1470 Genappe
- Names & denominations
- PHARMACIE DE BOUSVAL
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 20 March 2003
- Peppol
- Active · Active since 26 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers